Novel therapeutic bispecific antibodies for B-cell lymphoma
“Our results indicate that IgM-dependent bispecific antibodies are potent therapeutic agents for B-cell malignancies.”Credit: 2024 Ohashi et al. “Our results indicate that IgM-dependent bispecific antibodies...